Samir Mody as chief commercial officer, while
Friedrich Asmus signs on as SVP, clinical development and medical affairs. Meanwhile, the company has also tapped
Joel Centeno as SVP, manufacturing, quality and supply chain. Mody comes over from Medtronic, where he was vice president, CRHF strategy, health economics and reimbursement. Asmus previously served as VP of clinical development at ophthalmology biotech ProQR Therapeutics, while Centeno comes over after stints at Boston Scientific, Hologic and AltheaDx.
> Antios Therapeutics has tapped
Tamra Adams as chief financial officer, a newly created executive position at the company. Before joining Antios, Adams founded Accounting Concepts, which provided CFO, accounting, and financial services to emerging growth companies in the biopharmaceutical and information technology industries, including Engage Therapeutics.
Editas Medicine
James Mullen takes over as CEO from Feb. 15.
Editas chairman Mullen will don the CEO mantle Feb. 15, taking over for current Editas chief
Cynthia Collins. Before jumping to the Editas team, Mullen was CEO and director of the CDMO Patheon later snapped up by Thermo Fisher and also served as the CEO of Biogen. In a brief release, Editas didn’t say why Collins was leaving. “It has been a privilege to lead Editas Medicine and this extremely talented team,” she said in a statement. “I am particularly proud of the progress to the clinic we have made with both in vivo and ex vivo gene edited medicines.” Collins joined Editas in 2019, picking up the role from
LabCorp’s contract research organization business Covance has promoted Maryland Franklin, Ph.D., to vice president and head of its cell and gene therapy unit.
Highmark Health.
James joined Highmark in 2015 as supplier diversity director and developed the program into one of the top award-winning supplier diversity programs in the Americas, officials said.
James will work with Margaret Larkins-Pettigrew, M.D., who serves as Allegheny Health Network’s (AHN s) chief clinical diversity, equity and inclusion officer. James will implement and advise upon Highmark Health’s enterprisewide diversity, equity and inclusion strategy, while Larkins-Pettigrew will focus her efforts across AHN to shape an inclusive workplace culture, officials said.
James previously served as CEO of a diversity and inclusion consulting firm and in an advisory role with the Office of Minority and Women Inclusion at the U.S. Securities and Exchange Commission. As a practicing lawyer for more than 20 years, he spent several years facilitating historically black colleges and universities financings nationally for capital projects through a U.S. Department of Educat